![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.60 | 19.95 | 20.50 | - | 8,874 | 10:01:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -515.00 | 89.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2021 09:23 | Хор | ![]() volsung | |
01/3/2021 09:21 | Interesting that NG Soft generated that much profit...Just waiting for dividend announcement now. | ![]() paulisi | |
01/3/2021 07:02 | BATM Advanced Communications Ld Update on Sale of NGSoft March 01 2021 - 02:00AM UK Regulatory (RNS & others) TIDMBVC RNS Number : 6021Q BATM Advanced Communications Ld 01 March 2021 LEI: 213800FLQUB9J289RU66 1 March 2021 BATM Advanced Communications Limited ("BATM" or "the Group") Update on Sale of NGSoft Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer"). The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021. The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021. NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m. Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value." Enquiries: | ![]() wizzkid211 | |
26/2/2021 17:04 | Thanks FSE. Three main legs, all set for growth, would be a nicely broad spread as a base. Medical/NFVTime/Futu | ![]() hew | |
26/2/2021 15:17 | >hew.... you might find this interesting. Celitron sold the unit to a Belgium concern. Looks like Belgium is taking a major interest in Insect Protein. looks like there is more to this than we thought This is the Celitron unit | ![]() fse | |
26/2/2021 12:16 | Insect protein recovery play -tick Advanced covid testing play -tick Advanced ventilator manufacturer play tick, NFVTime play -tick Late stage trials POC infection testing -tick Agriculture biowaste disposal -tick $33 million in back pocket after legacy software sale -tick Not a bad company all in all | ![]() doccash | |
26/2/2021 10:01 | Substantial Telegraph article today. (Possibly subscribers only). Glad BATM well up with the hunt – if right word. RNS 7 Dec 2020: "BATM Delivers First Insect Protein Recovery Facility - New ISS-based instrument to produce high-quality insect protein powder and oil" Telegraph: "Why it’s time to embrace edible insects - As an alternative to meat, bugs are winning over everyone from farms to Hollywood celebrities" | ![]() hew | |
25/2/2021 17:26 | I know that Covid treatment has changed with CPAP first line then ventilation. However if they have the ability to manufacture a smart ventilator I doubt they will not be getting further orders worldwide | ![]() doccash | |
25/2/2021 17:15 | Very interesting article from ST with a few snippets that I hadn't seen.Expected dividend of 2p in AprilRevenues from NFV 3m and 10m in 2021 and 2022 respectively - conservative numbers.Expected significant growth even without the ventilator revenue, which may be a one off. | ![]() paulisi | |
25/2/2021 15:19 | The IC update from Simon Thompson is well worth reading. I agree with his conclusions FWIW. Typical PER for a large established NASDAQ company can be in the 40's. Companies like BATM at this stage are often loss making and dont have a PER. The company is turning in a good set of results and plans to pay a dividend and thats with the lions share of the company still in the developmental stage with the likes of NVFTime only starting to attract revenue. In the medical division numerous new highly advanced products are in final stages of certification which will be essential to the post Covid world. The recent set of results confirmed what ST, myself and others have been anticipating. The proof is in the pudding now and the pudding is on sale.... | ![]() fse | |
25/2/2021 12:21 | No probs Krutt. | ![]() silver surfer | |
25/2/2021 11:43 | I think this will end up flat on the day. MMs have tons of stock. Only way for a substantial increase is for a huge contract win. | ![]() leewain | |
25/2/2021 11:37 | I actually just subscribed to IC on the strength of the article. Thank You Silver Surfer! | ![]() krutt | |
25/2/2021 09:01 | Ummmm ... over 400,000 shares traded and it's only 9 am, and up 3.5p .... very interesting ... somebody's buying ... announcement coming ?? | ![]() rawdeal1 | |
25/2/2021 07:58 | Like the last 2 times? It hardly budged. The LT subscribers are already in it and just look at the increase already from when he first tipped it. | ![]() leewain | |
25/2/2021 07:55 | Hew - as an IC subscriber, concur with your comment. Leewain - ST has the ability to shift prices considerably, so hoping you’ll be proved wrong in the next few mins! | ![]() techno20 | |
24/2/2021 23:09 | It may be tipped but that doesn't make any difference to the share price PIs follow a company after doing their own research, I've seen IC tip this recently and it has hardly budged the share price RNS updates will move the price not some tipsters opinion. | ![]() leewain | |
24/2/2021 22:14 | Many don't agree (as shown above)and each to their own, but I prefer to give details only after paying subscribers have had a chance to read when the markets are open - say at 0830 tomorrow. (No personal issue on this occasion - I've already made a substantial top-up after seeing the Results.) | ![]() hew | |
24/2/2021 21:03 | IC article below. Not sure if it was the one Hew was referring to. | ![]() silver surfer | |
24/2/2021 19:23 | Do tell more it's a subscription only article | ![]() doccash | |
24/2/2021 18:57 | ST sees target 170p? Pah! History. After the market closed tonight IC put out a new ST article including a substantial boost to that. Also ST makes a specific statement re the projected disposal and gives Shore's forecasts including re the dividend. | ![]() hew | |
24/2/2021 10:11 | Yep, bargain @ 100p | carrotrunner | |
24/2/2021 05:22 | Thanks to all. Time to load up ! | ![]() emeraldzebra | |
23/2/2021 22:21 | The 15% markdown with low volume, on transformational results for BVC, says more about the floundering London market than BATM, and why many tech companies are sensibly opting to float Stateside rather than here, as ZVI will no doubt be considering for his company as well. | ![]() cumnor | |
23/2/2021 21:48 | The NFV licensing revenue is via two methods.Loading into chipsets via the chipset manufacturer.Sales of the box, of which BATM has other services for revenue - Celare product etc.I've no idea which will generate more income... | ![]() paulisi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions